Dear David,
I hope you travelled well back to Tbilisi.
Thank you for the invitation to join the Georgian meeting and reception during EASL it was a pleasure to catch up with you and the team.
I would like to ask if you are intending to participate in the World Health Assembly in Geneva 21 -23 May. We are organising some side meetings with some African and Asian Ministers of Health to discuss HEP C and would very much like to
invite you and your delegation to attend to assist the discussions by giving the very positive Georgian experience.
Please let me know if you would be available to attend and I will arrange for a formal invitation and logistics. I believe we would like to invite you even if you were not planning to attend the WHA.
Thank you for your consideration.
Best wishes
Graeme
Graeme.A Robertson
Senior Director, Africa & CIS
Access Operations & Emerging Markets
--------------------------------------------------------------------------------------------------------------------------------------------------
Gilead Sciences Europe Ltd
• Registered as a limited company in England and Wales • Registered number
05510315
Registered office:
South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England
Telephone:
+44(0)208 587 2228
• Mobile: +44(0)7789 268 043 • Fax:
+44(0)208 744 6773
DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information
which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the
information in it or in any attachments is strictly prohibited and may be unlawful. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete,
or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment
to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered
as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England